| P2093 | author name string | S Albers | |
| | J Weil | |
| | T S Mir | |
| | M Haddad | |
| | J Falkenberg | |
| | M Flato | |
| | R Budden | |
| | S Laer | |
| P2860 | cites work | Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review | Q30826404 |
| | Estrogen, natriuretic peptides and the renin-angiotensin system | Q33704109 |
| | Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure | Q34139611 |
| | Are natriuretic peptides clinically useful as markers of heart failure? | Q34195871 |
| | B-type natriuretic peptide levels: a potential novel "white count" for congestive heart failure | Q34290336 |
| | The physiological and pathophysiological modulation of the endocrine function of the heart | Q34370342 |
| | BNP and congestive heart failure | Q34635170 |
| | Plasma brain natriuretic peptide concentration: impact of age and gender | Q34843144 |
| | Influence of hypertension, left ventricular hypertrophy, and left ventricular systolic dysfunction on plasma N terminal proBNP. | Q35375245 |
| | Normal values of B type natriuretic peptide in infants, children, and adolescents | Q35581437 |
| | Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure | Q40618681 |
| | Cardiac hormones: diagnostic and therapeutic potential | Q41543840 |
| | N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) in different thyroid function states | Q44695303 |
| | B-type natriuretic peptide levels in congenital heart disease | Q48089433 |
| | Cardiac peptides differ in their response to exercise. Implications for patients with heart failure in clinical practice | Q48112030 |
| | Plasma Concentrations of Aminoterminal Pro Atrial Natriuretic Peptide and Aminoterminal Pro Brain Natriuretic Peptide in Healthy Neonates: Marked and Rapid Increase After Birth | Q48181927 |
| | Studies of cardiopulmonary bypass in children: implications for the regulation of brain natriuretic peptide. | Q48242684 |
| | Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment | Q48592649 |
| | ICH Harmonised Tripartite Guideline. Statistical principles for clinical trials. International Conference on Harmonisation E9 Expert Working Group | Q73110915 |
| | Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations | Q73736775 |
| | The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women | Q74208687 |
| | Natriuretic peptides | Q74817622 |
| | Estrogen regulation of angiotensin-converting enzyme mRNA | Q77945642 |
| P433 | issue | 1 | |
| P921 | main subject | teenager | Q1492760 |
| P304 | page(s) | 73-77 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Pediatric Cardiology | Q2232591 |
| P1476 | title | Plasma concentrations of N-terminal brain natriuretic peptide in healthy children, adolescents, and young adults: effect of age and gender | |
| P478 | volume | 27 | |